Circulating Tumour Cells, Circulating Tumour DNA and Circulating MicroRNA in Metastatic Breast Carcinoma - What is the Role of Liquid Biopsy in Breast Cancer?

被引:14
作者
Polasik, Arkadius [1 ]
Tzschaschel, Marie [1 ]
Schochter, Fabienne [1 ]
de Gregorio, Amelie [1 ]
Friedl, Thomas W. P. [1 ]
Rack, Brigitte [1 ]
Hartkopf, Andreas [2 ]
Fasching, Peter A. [3 ]
Schneeweiss, Andreas [4 ]
Mueller, Volkmar [5 ]
Huober, Jens [1 ]
Janni, Wolfgang [1 ]
Fehm, Tanja [6 ]
机构
[1] Univ Klinikum Ulm, Klin Gynakol & Geburtshilfe, Ulm, Germany
[2] Univ Klinikum Tubingen, Klin Gynakol & Geburtshilfe, Tubingen, Germany
[3] Univ Klinikum Erlangen, Klin Gynakol & Geburtshilfe, Erlangen, Germany
[4] Univ Klinikum Heidelberg, Natl Ctr Tumorerkrankungen, Heidelberg, Germany
[5] Univ Klinikum Hamburg Eppendorf, Klin Gynakol & Geburtshilfe, Hamburg, Germany
[6] Heinrich Heine Univ Dusseldorf, Klin Gynakol & Geburtshilfe, Dusseldorf, Germany
关键词
breast; Her-2/neu (human epidermal growth factor recptor); hormonal receptor; mammary gland tumor; metastasis; POOLED ANALYSIS; HER2; STATUS; ESTROGEN-RECEPTOR; PIK3CA MUTATIONS; ESR1; MUTATIONS; BONE-MARROW; RESISTANCE; DISEASE; MARKER; SITES;
D O I
10.1055/s-0043-122884
中图分类号
R71 [妇产科学];
学科分类号
100211 ;
摘要
Dissemination of tumour cells and the development of solid metastases occurs via blood vessels and lymphatics. Circulating tumour cells (CTCs) and circulating tumour DNA (ctDNA) can be detected in venous blood in patients with early and metastatic breast cancer, and their prognostic relevance has been demonstrated on numerous occasions. Repeated testing for CTCs and ctDNA, or regular so-called "liquid biopsy", can be performed easily at any stage during the course of disease. Additional molecular analysis allows definition of tumour characteristics and heterogeneity that may be associated with treatment resistance. This in turn makes personalised, targeted treatments possible that may achieve both improved overall survival and quality of life.
引用
收藏
页码:1291 / 1298
页数:8
相关论文
共 46 条
[21]   Pooled Analysis of the Prognostic Relevance of Circulating Tumor Cells in Primary Breast Cancer [J].
Janni, Wolfgang J. ;
Rack, Brigitte ;
Terstappen, Leon W. M. M. ;
Pierga, Jean-Yves ;
Taran, Florin-Andrei ;
Fehm, Tanja ;
Hall, Carolyn ;
de Groot, Marco R. ;
Bidard, Francois-Clement ;
Friedl, Thomas W. P. ;
Fasching, Peter A. ;
Brucker, Sara Y. ;
Pantel, Klaus ;
Lucci, Anthony .
CLINICAL CANCER RESEARCH, 2016, 22 (10) :2583-2593
[22]   PIK3CA Mutations May Be Discordant between Primary and Corresponding Metastatic Disease in Breast Cancer [J].
Jensen, Jeanette Dupont ;
Laenkholm, Anne-Vibeke ;
Knoop, Ann ;
Ewertz, Marianne ;
Bandaru, Raj ;
Liu, Weihua ;
Hackl, Wolfgang ;
Barrett, J. Carl ;
Gardner, Humphrey .
CLINICAL CANCER RESEARCH, 2011, 17 (04) :667-677
[23]   Association between gain-of-function mutations in PIK3CA and resistance to HER2-targeted agents in HER2-amplified breast cancer cell lines [J].
Kataoka, Y. ;
Mukohara, T. ;
Shimada, H. ;
Saijo, N. ;
Hirai, M. ;
Minami, H. .
ANNALS OF ONCOLOGY, 2010, 21 (02) :255-262
[24]   THE C-ELEGANS HETEROCHRONIC GENE LIN-4 ENCODES SMALL RNAS WITH ANTISENSE COMPLEMENTARITY TO LIN-14 [J].
LEE, RC ;
FEINBAUM, RL ;
AMBROS, V .
CELL, 1993, 75 (05) :843-854
[25]  
LEON SA, 1977, CANCER RES, V37, P646
[26]  
Lo YMD, 2000, CLIN CHEM, V46, P319
[27]   ctDNA dynamics: a novel indicator to track resistance in metastatic breast cancer treated with anti-HER2 therapy [J].
Ma, Fei ;
Zhu, Wenjie ;
Guan, Yanfang ;
Yang, Ling ;
Xia, Xuefeng ;
Chen, Shanshan ;
Li, Qiao ;
Guan, Xiuwen ;
Yi, Zongbi ;
Qian, Haili ;
Yi, Xin ;
Xu, Binghe .
ONCOTARGET, 2016, 7 (40) :66020-66031
[28]   Circulating miRNAs with prognostic value in metastatic breast cancer and for early detection of metastasis [J].
Madhavan, Dharanija ;
Peng, Cike ;
Wallwiener, Markus ;
Zucknick, Manuela ;
Nees, Juliane ;
Schott, Sarah ;
Rudolph, Anja ;
Riethdorf, Sabine ;
Trumpp, Andreas ;
Pantel, Klaus ;
Sohn, Christof ;
Chang-Claude, Jenny ;
Schneeweiss, Andreas ;
Burwinkel, Barbara .
CARCINOGENESIS, 2016, 37 (05) :461-470
[29]   Circulating tumor DNA and circulating tumor cells in metastatic triple negative breast cancer patients [J].
Madic, Jordan ;
Kiialainen, Anna ;
Bidard, Francois-Clement ;
Birzele, Fabian ;
Ramey, Guillemette ;
Leroy, Quentin ;
Frio, Thomas Rio ;
Vaucher, Isabelle ;
Raynal, Virginie ;
Bernard, Virginie ;
Lermine, Alban ;
Clausen, Inga ;
Giroud, Nicolas ;
Schmucki, Roland ;
Milder, Maud ;
Horn, Carsten ;
Spleiss, Olivia ;
Lantz, Olivier ;
Stern, Marc-Henri ;
Pierga, Jean-Yves ;
Weisser, Martin ;
Lebofsky, Ronald .
INTERNATIONAL JOURNAL OF CANCER, 2015, 136 (09) :2158-2165
[30]  
MANDEL P, 1948, CR SOC BIOL, V142, P241